UPDATE FROM THE RBM SECRETARIAT. David Alnwick Project Manager RBM Global Partners’ Meeting Washington, DC April 18 - 19, 2001. Malaria Burden. One fifth of the world population at risk in over 100 malaria endemic countries Facing a huge disease burden
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
UPDATE FROM THE RBM SECRETARIAT
David AlnwickProject Manager RBMGlobal Partners’ MeetingWashington, DC April 18 - 19, 2001
GNP per capita (1995)
To halve global malaria
burden by 2010
Global partners have made progress in the development of:
Cost-effectiveness in a very low income country with high transmission: mean and 90% range for the cost/DAYLY adverted (1995 US dollars)
DDT continues to available to those countries that need it to roll back malaria
Efforts are made to make accessible alternative vector control tools
Compare where the outbreaks occur with current
distribution of partners
Maximize resources in most needed areas
Functioning country partnership:
Progress 5:Dynamic Global Movement
3. RESOLVE TO:
Initiate appropriate and sustainable action to strengthen the health systems to ensure that by the year 2005,
At least 60% of those suffering from malaria have prompt access to and are able to use correct, affordable and
appropriate treatment within 24 hours of the onset of symptoms.
At least 60% of those at risk of malaria particularly pregnant women and children under five years of age, benefit from the most suitable combination of personal and community protective measures such as insecticide treated mosquito nets and other interventions which are accessible and affordable to prevent infection and suffering.
At least 60% of all pregnant women who are at risk of malaria, especially those in their first pregnancies, have access to chemoprophylaxis or presumptive intermittent treatment.